GBS Venture Partners: Funding, Team & Investors | Startup Intros

Loading organizations...

GBS Venture Partners: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2016	Elastagen	$9.0M Series B	—	Korea Investment Partners, AMOREPACIFIC Ventures, ATP Innovations, Brandon Capital
Sep 1, 2014	Ivantis	$25.0M Series B	—	Alafi Capital, Ascension Ventures, Delphi Ventures, EDBI, Jim Tananbaum, MemorialCare, New Enterprise Associates, Vertex Ventures
Apr 3, 2014	Neurovance	$6.3M Series A Extension	—	Tim Barberich, Hambrecht & Quist Capital Management, H&Q Healthcare Investors, Novartis, State of Wisconsin Investment Board, Venture Investors
Apr 1, 2014	Spinifex Pharmaceuticals	$45.0M Series C	Heath Lukatch	Brandon Capital Partners, Canaan Partners, Red Tree Venture Capital, Brandon Capital, Brent Ahrens, Uniquest, Uniseed
Jan 1, 2014	Ivantis	$14.0M Series B	—	Alafi Capital, Ascension Ventures, Delphi Ventures, EDBI, MemorialCare, NEA, Vertex Ventures
Oct 18, 2012	Neurovance	$7.0M Series A	Novartis	Tim Barberich, H&Q Healthcare Investors, H&Q Life Sciences Investors, State of Wisconsin Investment Board, Venture Investors
Jul 1, 2012	Ocunexus Therapeutics	$20.0M Series B	—	Domain Associates, Kleiner Perkins, Versant Ventures, BioPacificVentures, RusnanoMedInvest
Jan 1, 2012	AirXpanders	$10.0M Series D	Albert Cha	Frazier Healthcare Partners, Vivo Capital, Heron Capital, Prolog Ventures, Western Technology Investment
Aug 1, 2011	Spinifex Pharmaceuticals	$19.0M Series B	—	Brandon Capital Partners, Brandon Capital, Uniquest, Uniseed
May 25, 2011	Pathway Therapeutics	$7.5M Other Equity	CM Capital, GBS Venture Partners	—
Apr 1, 2011	Ocunexus Therapeutics	$19.0M Series B	—	Domain Associates, Kleiner Perkins, Versant Ventures, BioPacificVentures
Mar 9, 2011	Euthymics Bioscience	$4.0M Series A Extension	Novartis, Venture Investors	Tim Barberich, H&Q Healthcare Investors, H&Q Life Sciences Investors
Aug 10, 2010	Pathway Therapeutics	$4.5M Series A Extension	CM Capital, GBS Venture Partners	Breast Cancer Research Trust, New Zealand Growth Capital Partners, Trans Tasman Commercialisation Fund
Jul 22, 2010	Euthymics Bioscience	$24.0M Series A	Campbell Murray, Paul Weiss	Andrew Baker, Frank Gentile, State of Wisconsin Investment Board
Jul 1, 2010	Uptake Medical	$18.0M Series B	Eric J. Kim	Arboretum Ventures, FJ Labs, Founder Collective, Goodwater Capital, Illuminate Ventures, Perseverance Capital, Primary Venture Partners, Tekton Ventures, Michael Moritz, Affinity Capital, ONSET Ventures, WRF Capital
Sep 1, 2008	Spinifex Pharmaceuticals	$10.0M Series A	—	Brandon Capital Partners, Chris Nave, Andrew Baker, Uniseed
May 1, 2006	Uptake Medical	$9.0M Series A	John Brooks	Arboretum Ventures, Perseverance Capital, Dan Sheehan, Geoff Brooke, Robert Kuhling, Thong Le